Steven Cohen’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Steven Cohen’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-528,169	Closed	-$2.96M	–	1231
2021 Q1	$2.96M	Buy	+528,169	New	+$3.2M	0.01%	676
2020 Q3	–	Sell	-62,615	Closed	-$1.8M	–	1146
2020 Q2	$1.8M	Buy	+62,615	New	+$1.45M	0.01%	610

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Steven Cohen's STSA Position: Q2 2021 in Review

Steven Cohen sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2021, closing a stake of 528,169 shares — an estimated $2.96M sold.

Steven Cohen first reported a position in STSA in Q2 2020 and held it in 2 quarters. The position peaked at $2.96M in Q1 2021. 60 funds tracked by Wall St. Rank hold STSA as of Q2 2021.

Steven Cohen reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Steven Cohen sold 528,169 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $2.96M.
Steven Cohen first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
Steven Cohen's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $2.96M in Q1 2021.
60 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.